We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




siRNA Design Criteria and Validation Data

By Biotechdaily staff writers
Posted on 12 Feb 2004
Eight previously undisclosed small interfering RNA (siRNA) design criteria along with the data validating their functionality in gene silencing have been published in a scientific paper appearing in the February 1, 2004, online issue of Nature Biotechnology.

The design criteria were developed by Dharmacon, Inc. More...
(Lafayette, CO, USA), which has employed rational methods for siRNA design since 2002. The basis for this rational design was extended to a total of 25 criteria forming the foundation of the company's Smartselection technology platform. Smartselection design significantly enhances the probability of efficient silencing and provides a high degree of potency and specificity. Dharmacon is making all eight of the disclosed criteria available through its online siRNA design tool, siDesign Center.

In the published paper, Dharmacon scientists identify eight criteria associated with siRNA by performing a systematic analysis of a large set of siRNAs targeting multiple genes. Each individual criterion alone is not sufficient to ensure gene silencing, but incorporating all eight into a single multi-component algorithm was over 96% effective in predicting functional siRNAs. The criteria include internal thermodynamic stability, a lack of internal repeats, and positional sequence-specific determinants.


"We felt it was time to elevate the current standard of publicly available design tools by making the eight criteria available to the scientific community through our free online siDesign Center siRNA design tool,” said Stephan A. Scaringe, Ph.D., co-chairman and chief scientific officer of Dharmacon.




Related Links:
Dharmacon

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.